Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Winder

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Prostate|September 22, 2012
Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancerA Mitchell, G Mathew, T Jiang, et al.
The Biochemical Journal|December 15, 1993
Calponin phosphorylation in vitro and in intact muscleS J Winder, B G Allen, E D Fraser, et al.
Trends in Biochemical Sciences|April 1, 1995
Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactionsD J Blake, J M Tinsley, K E Davies, et al.
Human Molecular Genetics|June 4, 2004
Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycanH J Spence, Y-J Chen, C L Batchelor, et al.
Neoplasia (New York, N.Y.)|August 9, 2001
The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cellsV G Brunton, V J Fincham, G W McLean, et al.
FEBS Letters|January 30, 1995
Full-length and short forms of utrophin, the dystrophin-related proteinT M Nguyen, T R Helliwell, C Simmons, et al.
Biochemical Society Transactions|August 1, 1995
Calmodulin regulation of utrophin actin bindingS J Winder, L Hemmings, S J Bolton, et al.
Journal of Cell Science|January 1, 1995
Utrophin actin binding domain: analysis of actin binding and cellular targetingS J Winder, L Hemmings, S K Maciver, et al.
Scientific Reports|October 1, 2013
Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancerG Mathew, A Mitchell, J M Down, et al.
Histopathology|November 6, 2008
Expression of beta-dystroglycan is reduced or absent in many human carcinomasS S Cross, J Lippitt, A Mitchell, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Prostate|September 22, 2012
Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancerA Mitchell, G Mathew, T Jiang, et al.
The Biochemical Journal|December 15, 1993
Calponin phosphorylation in vitro and in intact muscleS J Winder, B G Allen, E D Fraser, et al.
Trends in Biochemical Sciences|April 1, 1995
Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactionsD J Blake, J M Tinsley, K E Davies, et al.
Human Molecular Genetics|June 4, 2004
Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycanH J Spence, Y-J Chen, C L Batchelor, et al.
Neoplasia (New York, N.Y.)|August 9, 2001
The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cellsV G Brunton, V J Fincham, G W McLean, et al.
FEBS Letters|January 30, 1995
Full-length and short forms of utrophin, the dystrophin-related proteinT M Nguyen, T R Helliwell, C Simmons, et al.
Biochemical Society Transactions|August 1, 1995
Calmodulin regulation of utrophin actin bindingS J Winder, L Hemmings, S J Bolton, et al.
Journal of Cell Science|January 1, 1995
Utrophin actin binding domain: analysis of actin binding and cellular targetingS J Winder, L Hemmings, S K Maciver, et al.
Scientific Reports|October 1, 2013
Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancerG Mathew, A Mitchell, J M Down, et al.
Histopathology|November 6, 2008
Expression of beta-dystroglycan is reduced or absent in many human carcinomasS S Cross, J Lippitt, A Mitchell, et al.
Pageof 5